NCT04629729 2026-03-19
FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Phase 1 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Bendamustine Hydrochloride × Clear all